Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Lung
Published in: Lung 1/2002

01-02-2002

Pleural Effusion and Serum Soluble Fas-Ligand Levels Are Elevated in Different Clinical Conditions

Authors: P.S. Wang, Y.M. Chen, Y.L. Hsieh, C.F. Yu, C.M. Tsai, R.P. Perng

Published in: Lung | Issue 1/2002

Login to get access
Metadata
Title
Pleural Effusion and Serum Soluble Fas-Ligand Levels Are Elevated in Different Clinical Conditions
Authors
P.S. Wang
Y.M. Chen
Y.L. Hsieh
C.F. Yu
C.M. Tsai
R.P. Perng
Publication date
01-02-2002
Publisher
Springer-Verlag
Published in
Lung / Issue 1/2002
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s004080000078

Other articles of this Issue 1/2002

Lung 1/2002 Go to the issue

OriginalPaper

Central Fatigue of the Diaphragm and Quadriceps During Incremental Loading

OriginalPaper

Developmental Regulation of SP-A Receptor in Fetal Rat Lung

OriginalPaper

Activation of Protein C Pathway in the Airways

OriginalPaper

Additive Effect of Interleukin-12 and Interleukin-18 on the T-helper Cell Pathway of Malignant Pleural Effusion

Announcement

Announcement
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits